Evaluation the efficacy of three brands of Ceftriaxone against various strains of bacteria by measuring zone of inhibition
DOI:
https://doi.org/10.54361/ljmr.v14i2.03Keywords:
Ceftriaxone, Zone of Inhibition, antibacterial efficacyAbstract
Ceftriaxone (Rocephin)is wide spectrum cephalosporin that has been used for decades for combating infections caused by broad array of pathogens. In this study, the antibiotic ceftriaxone from three different brands was tested for its effectiveness against strains of bacteria like Streptococcus pyrogens, Staphylococcus aureus and Klebsiella pneumonia. The effectiveness of ceftriaxone was estimated by measuring zone of inhibition and compared with standard disc (BD BBL Sensi-Disc 2004/09). The diameters of the inhibitory zones for all brands were ranged from 20 to 33mm±0.5. The present study showed that there is no significant variation amongst the different brands of ceftriaxone in term of their antibacterial effectiveness.
Downloads
References
Nath SK, Foster GA, Mandell LA, Rotstein C. Antimicrobial activity of ceftriaxone versus cefotaxime: negative effect of serum albumin binding of ceftriaxone. J AntimicrobChemother1994 Jun;33(6):1239-1243.
Masood H, Naqvi SB, Aslam N. Cost effective analysis of different brands of ceftriaxone available in Karachi Pakistan. Pak J Pharmacol 2008;25:13-19.
Gian Maria Pacifici, Giovanna Marchini11 Clinical Pharmacology of Ceftriaxone in Neonates and Infants: Effects and Pharmacokinetics Systematic Review (Pages: 5751-5777).
Hwang KP, Tang YF, Shen YH. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteraemia. J. Microbial Immunol Infect 2009 Oct;42(5):433-438.
James, C., (2011): Instructor’s guide for microbiology: A laboratory manual. 10th ed. Paperback: Addison Wesley.
Clinical and laboratory standards institute, (2004): 2nd ed.[CLSI].
Hudzicki, J. Kirby-Bauer Disk Diffusion Susceptibility Test Protocol. ASM Microbe Library. American Society for Microbiology, (2009): http://www.microbelibrary.org/component/resource/laboratorytest/3189-kirby-bauer-disk-diffusion-susceptibility-test-protocol
BNF 57, (March 2009): Wholly-owned published, BMJ group and RPS publishing ISBN: 9780853698456.
Syed HA. Masoodand Nousheen Aslam. In Vitro Susceptibility Test of Different Clinical Isolates against Ceftriaxone. Oman Medical Journal 2010, Volume 25, Issue 3.
Thapa B, Mahat K. In-vitro Activity of Three Brands of Ceftriaxone against different Clinical Isolates. 2010;49(179):225-7.
Fanta Gashe, Eshetu Mulisa, Mekidim Mekonnen, Gemechu Zeleke. Antimicrobial Resistance Profile of Different Clinical Isolates against Third-Generation Cephalosporins. Journal of Pharmaceutics.2018. 5070742, 7.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Ibrahim Egfair, Ryad M. O. Alati, Abdullah M. O. Bakoosh, AbuAjeela M. Alfalos, Mahmoud A. L. Ruaua, Ashraf A. Naass, Waleed R. A. Abusittah, Mahmud E. L. Abushhewa (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
